BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 26857415)

  • 1. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    Neurosci Lett; 2018 Sep; 683():168-173. PubMed ID: 30075285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies.
    Ishii K; Hosaka K; Mori T; Mori E
    Ann Nucl Med; 2004 Jul; 18(5):447-51. PubMed ID: 15462408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.
    Ingram M; Colloby SJ; Firbank MJ; Lloyd JJ; O'Brien JT; Taylor JP
    Psychiatry Res Neuroimaging; 2022 Jun; 322():111460. PubMed ID: 35247828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
    O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
    J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
    Kono AK; Ishii K; Sofue K; Miyamoto N; Sakamoto S; Mori E
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1490-7. PubMed ID: 17318545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
    Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
    Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.
    Ishii K; Kanda T; Uemura T; Miyamoto N; Yoshikawa T; Shimada K; Ohkawa S; Minoshima S
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):831-40. PubMed ID: 19148640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.